` EMR (Emerald Resources NL) vs S&P/ASX 300 Comparison - Alpha Spread

EMR
vs
S
S&P/ASX 300

Over the past 12 months, EMR has underperformed S&P/ASX 300, delivering a return of +4% compared to the S&P/ASX 300's +10% growth.

Stocks Performance
EMR vs S&P/ASX 300

Loading
EMR
S&P/ASX 300
Add Stock

Performance Gap
EMR vs S&P/ASX 300

Loading
EMR
S&P/ASX 300
Difference
www.alphaspread.com

Performance By Year
EMR vs S&P/ASX 300

Loading
EMR
S&P/ASX 300
Add Stock

Competitors Performance
Emerald Resources NL vs Peers

S&P/ASX 300
EMR
601899
NEM
AEM
GGP
Add Stock

Emerald Resources NL
Glance View

Emerald Resources NL is a company that has carved a niche in the mining sector, primarily focusing on gold exploration and production. Its flagship project, the Okvau Gold Project, is situated in northeastern Cambodia, an area that has increasingly captured the attention of global mining firms due to its untapped mineral potential. The company's strategic approach centers around leveraging its experienced management team and utilizing modern exploration techniques to efficiently bring projects to production. By developing a robust production infrastructure and closely managing costs, Emerald Resources aims to achieve a strong operational footing, positioning itself to benefit from the long-term demand for gold. The company's revenue model is relatively straightforward; it makes money by extracting gold and selling it on the global market. However, the path to profitability involves more than just digging gold out of the ground. Emerald Resources has focused its efforts on optimizing the operational aspects of mining, from ensuring regulatory compliance to streamlining logistics and processing. The company's ability to execute its mining operations economically is crucial, as it directly affects margins in a market where prices can be volatile. Their ongoing commitment to corporate social responsibility, particularly in sustainable environmental practices and community engagement, seeks to bolster its reputation and operational stability, building trust with stakeholders while ensuring the longevity of its operations.

EMR Intrinsic Value
21.93 AUD
Undervaluation 82%
Intrinsic Value
Price
Back to Top